临床试验/PER-003-02

PER-003-02已完成未知

THERAPEUTIC ALTERNATIVES FOR THE TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C

SCHERING PLOUGH RESEARCH INSTITUTE,0 个研究点目标入组 0 人开始时间: 2002年1月7日最近更新: 2023年9月4日

试验速览

阶段: 未知
状态: 已完成
发起方: SCHERING PLOUGH RESEARCH INSTITUTE,

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

暂无简介。

研究设计

研究类型: Interventional

入排标准

入选标准

•1) Patients with chronic hepatitis C.
•2) Anti-HCV positive by enzyme immunoassay (ELIZA) of second generation or recombinant Immunoblot (RIBA).

排除标准

•Any other etiology of liver disease, based on clinical history and biopsy (if necessary), other than chronic hepatitis C.

研究者

发起方

SCHERING PLOUGH RESEARCH INSTITUTE,

相似试验

Epidemiology and therapeutic interventions for patellofemoral pain in recreational cyclistspatellofemoral pain

PACTR202001858319374SEMLI at the University of Pretoria100

Palmitoylethanolamide as adjunctive treatment of Autism: A double blind and placebo controlled trialChildhood autism.Childhood autism

IRCT201702171556N96Tehran University of Medical Sciences50

Presentation of patients with Tb lymph node and their response on therapy

CTRI/2023/10/058874Maulana Azad Medical College

ATAZANAVIR (BMS-232632) FOR THE TREATMENT OF PATIENTS INFECTED WITH HIV WHO COMPLETED THE CLINICAL TRIALS WITH ATAZANAVIR: A STUDY OF EXTENDED ACCESS.

PER-069-02BRISTOL MYERS SQUIBB PERU S.A.,

Homoeopathic treatment with therapy for Pain Management in Cancer Patients.

CTRI/2023/11/060290Central Council for Research in Homeopathy Ministry Ministry of Ayush